Company intelligence / Profile preview

Chemclin Diagnostics

Beijing, Beijing Municipality / Beijing City, Chinachemclin.com ↗

Ownership: Private
Employees: ~629
Development stage: Other

Overview

Chemclin Diagnostics develops and markets a broad portfolio of clinical diagnostic reagents and automated instruments based on proprietary light-induced chemiluminescence technology. Its products are widely used for infectious disease screening as well as tumor marker detection and hormone analysis. The company operates primarily in the Chinese domestic market with commercialized products.

Therapeutic areas: Infectious DiseasesEndocrinologyOncologyImmunologyCardiovascular
Modalities: Device (diagnostic instruments)Diagnostic reagent (immunoassay reagents)Biologic (for immunoassays)Enzymatic chemiluminescence reagent
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Chemclin Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemclin Diagnostics.

Explore the full profile